A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
NCT07029828
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Alopecia Areata
Interventions
DRUG:
Ritlecitinib higher dose
DRUG:
Ritlecitinib lower dose
Sponsor
Pfizer